Relapsed or Refractory T Cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed or Refractory T Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma (NCT05079282) | Ono Pharmaceutical Co., Ltd. | 2021-12-10 |
Track Relapsed or Refractory T Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.